Publicacions
-
Rössler J, Baselga E, Davila V, Celis-Passini V, Diociaiuti A, El Hachem M, Mestre S, Haeberli D, Prokop A, Hanke C, Loichinger W, Quéré I, Baumgartner I, Niemeyer CM and Kapp FG.
Severe adverse events during sirolimus "off-label" therapy for vascular anomalies
PEDIATRIC BLOOD & CANCER . 68(8): . Nº de cites: 32
-
Cruz-Martínez O, Caloretti V, Salvador-Hernandez H, Celis-Passini V, Santa-María López V, Morales-La Madrid A, Suñol M, Puerta P, Muchart-Lopez J, Krauel L and Lavarino C.
Synchronous choroid plexus papilloma and Wilms tumor in a girl, disclosing a Li-Fraumeni syndrome
HEREDITARY CANCER IN CLINICAL PRACTICE . 19(1): 1-1. Nº de cites: 2
-
Ramis-Zaldivar JE, Gonzalez-Farre B, Balagué O, Celis-Passini V, Nadeu F, Salmeron-Villalobos J, Andres M, Martin-Guerrero I, Garrido-Pontnou M, Gaafar A, Suñol M, Barcena C, Garcia-Bragado F, Andión M, Azorín D, Astigarraga I, Sagaseta de Ilurdoz M, Sábado C, Gallego S, Verdu-Amorós J, Fernandez-Delgado R, Perez V, Tapia G, Mozos A, Torrent M, Solano-Páez P, Rivas-Delgado A, Dlouhy I, Clot G, Enjuanes A, López-Guillermo A, Galera PK, Oberley MJ, Maguire A, Ramsower C, Rimsza LM, Quintanilla-Martinez L, Jaffe ES, ELENA CAMPO and Salaverria I.
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma
Blood . 135(4): 274-286. Nº de cites: 98
-
Gonzalez-Farre B, Ramis-Zaldivar JE, Salmeron-Villalobos J, Balagué O, Celis-Passini V, Verdu-Amoros J, Nadeu F, Sábado C, Ferrández A, Garrido M, García-Bragado F, de la Maya MD, Vagace JM, Panizo CM, Astigarraga I, Andrés M, Jaffe ES, ELENA CAMPO and Salaverria I.
Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.
HAEMATOLOGICA . 104(9): 1822-1829. Nº de cites: 77
-
Deyà-Martinez A, Esteve-Solé A, Vélez-Tirado N, Celis-Passini V, Costa-Colomer J, Cols M, Jou-Munoz C, Vlagea A, Plaza-Martín AM, Juan-Otero M and Alsina L.
Sirolimus as an alternative treatment in patients with granulomatous-lymphocytic lung disease and humoral immunodeficiency with impaired regulatory T cells
PEDIATRIC ALLERGY AND IMMUNOLOGY . 29(4): 425-432. Nº de cites: 30
-
Celis-Passini V, de Torres C, Parareda A, Rodriguez N, Torner-Rubies F, Cruz-Martínez O and Mora J.
Treatment of Newly Diagnosed Ewing Sarcoma with Gemcitabine and Docetaxel as an Alternative to Conventional Therapy in 2 patients Who Did Not Wish to Undergo Intensive Chemotherapy
Oncopedia . : 584.